Terms: = Prostate cancer AND TCF7L2, ENSG00000148737, 6934, TCF-4
23 results:
1. Whole-exome sequencing analysis of NSCLC reveals the pathogenic missense variants from cancer-associated genes.
Kumar S U; Balasundaram A; Cathryn R H; Varghese RP; R S; R G; Younes S; Zayed H; Doss C GP
Comput Biol Med; 2022 Sep; 148():105701. PubMed ID: 35753820
[TBL] [Abstract] [Full Text] [Related]
2. RANKL immunisation inhibits prostate cancer metastasis by modulating EMT through a RANKL-dependent pathway.
Park M; Cho YJ; Kim B; Ko YJ; Jang Y; Moon YH; Hyun H; Lim W
Sci Rep; 2021 Jun; 11(1):12186. PubMed ID: 34108600
[TBL] [Abstract] [Full Text] [Related]
3. Ormeloxifene Suppresses prostate Tumor Growth and Metastatic Phenotypes via Inhibition of Oncogenic β-catenin Signaling and EMT Progression.
Hafeez BB; Ganju A; Sikander M; Kashyap VK; Hafeez ZB; Chauhan N; Malik S; Massey AE; Tripathi MK; Halaweish FT; Zafar N; Singh MM; Yallapu MM; Chauhan SC; Jaggi M
Mol Cancer Ther; 2017 Oct; 16(10):2267-2280. PubMed ID: 28615299
[TBL] [Abstract] [Full Text] [Related]
4. Genetic interaction analysis of tcf7l2 for biochemical recurrence after radical prostatectomy in localized prostate cancer.
Chen CS; Huang CY; Huang SP; Lin VC; Yu CC; Chang TY; Bao BY
Int J Med Sci; 2015; 12(3):243-7. PubMed ID: 25678841
[TBL] [Abstract] [Full Text] [Related]
5. Association of variants in genes related to the immune response and obesity with BPH in CLUE II.
Lopez DS; Peskoe SB; Tsilidis KK; Hoffman-Bolton J; Helzlsouer KJ; Isaacs WB; Smith MW; Platz EA
Prostate Cancer Prostatic Dis; 2014 Dec; 17(4):353-8. PubMed ID: 25224558
[TBL] [Abstract] [Full Text] [Related]
6. tcf7l2 type 2 diabetes risk variant, lifestyle factors, and incidence of prostate cancer.
Drake I; Wallström P; Hindy G; Ericson U; Gullberg B; Bjartell A; Sonestedt E; Orho-Melander M; Wirfält E
Prostate; 2014 Sep; 74(12):1161-70. PubMed ID: 24961829
[TBL] [Abstract] [Full Text] [Related]
7. Androgen receptor (AR) suppresses normal human prostate epithelial cell proliferation via AR/β-catenin/tcf-4 complex inhibition of c-MYC transcription.
Antony L; van der Schoor F; Dalrymple SL; Isaacs JT
Prostate; 2014 Aug; 74(11):1118-31. PubMed ID: 24913829
[TBL] [Abstract] [Full Text] [Related]
8. Comprehensive functional annotation of 77 prostate cancer risk loci.
Hazelett DJ; Rhie SK; Gaddis M; Yan C; Lakeland DL; Coetzee SG; ; ; Henderson BE; Noushmehr H; Cozen W; Kote-Jarai Z; Eeles RA; Easton DF; Haiman CA; Lu W; Farnham PJ; Coetzee GA
PLoS Genet; 2014 Jan; 10(1):e1004102. PubMed ID: 24497837
[TBL] [Abstract] [Full Text] [Related]
9. Association between tcf7l2 gene polymorphism and cancer risk: a meta-analysis.
Chen J; Yuan T; Liu M; Chen P
PLoS One; 2013; 8(8):e71730. PubMed ID: 23951231
[TBL] [Abstract] [Full Text] [Related]
10. Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and prostate cancer Cohort Consortium.
Machiela MJ; Lindström S; Allen NE; Haiman CA; Albanes D; Barricarte A; Berndt SI; Bueno-de-Mesquita HB; Chanock S; Gaziano JM; Gapstur SM; Giovannucci E; Henderson BE; Jacobs EJ; Kolonel LN; Krogh V; Ma J; Stampfer MJ; Stevens VL; Stram DO; Tjønneland A; Travis R; Willett WC; Hunter DJ; Le Marchand L; Kraft P
Am J Epidemiol; 2012 Dec; 176(12):1121-9. PubMed ID: 23193118
[TBL] [Abstract] [Full Text] [Related]
11. Microsatellite markers for linkage and association studies.
Gulcher J
Cold Spring Harb Protoc; 2012 Apr; 2012(4):425-32. PubMed ID: 22474656
[TBL] [Abstract] [Full Text] [Related]
12. Anti-proliferative potential of curcumin in androgen-dependent prostate cancer cells occurs through modulation of the Wingless signaling pathway.
Teiten MH; Gaascht F; Cronauer M; Henry E; Dicato M; Diederich M
Int J Oncol; 2011 Mar; 38(3):603-11. PubMed ID: 21240460
[TBL] [Abstract] [Full Text] [Related]
13. Diabetes genes and prostate cancer in the Atherosclerosis Risk in Communities study.
Meyer TE; Boerwinkle E; Morrison AC; Volcik KA; Sanderson M; Coker AL; Pankow JS; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):558-65. PubMed ID: 20142250
[TBL] [Abstract] [Full Text] [Related]
14. Long-range enhancers on 8q24 regulate c-Myc.
Sotelo J; Esposito D; Duhagon MA; Banfield K; Mehalko J; Liao H; Stephens RM; Harris TJ; Munroe DJ; Wu X
Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3001-5. PubMed ID: 20133699
[TBL] [Abstract] [Full Text] [Related]
15. No effect of cancer-associated SNP rs6983267 in the 8q24 region on co-expression of MYC and tcf7l2 in normal colon tissue.
Prokunina-Olsson L; Hall JL
Mol Cancer; 2009 Nov; 8():96. PubMed ID: 19895682
[TBL] [Abstract] [Full Text] [Related]
16. Activator protein 2alpha suppresses intestinal tumorigenesis in the Apc(min) mouse.
Li Q; Löhr CV; Dashwood RH
Cancer Lett; 2009 Sep; 283(1):36-42. PubMed ID: 19376641
[TBL] [Abstract] [Full Text] [Related]
17. Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II.
Wang MH; Helzlsouer KJ; Smith MW; Hoffman-Bolton JA; Clipp SL; Grinberg V; De Marzo AM; Isaacs WB; Drake CG; Shugart YY; Platz EA
Prostate; 2009 Jun; 69(8):874-85. PubMed ID: 19267370
[TBL] [Abstract] [Full Text] [Related]
18. Evaluation of a variant in the transcription factor 7-like 2 (tcf7l2) gene and prostate cancer risk in a population-based study.
Agalliu I; Suuriniemi M; Prokunina-Olsson L; Johanneson B; Collins FS; Stanford JL; Ostrander EA
Prostate; 2008 May; 68(7):740-7. PubMed ID: 18302196
[TBL] [Abstract] [Full Text] [Related]
19. Variation in tcf7l2 and increased risk of colon cancer: the Atherosclerosis Risk in Communities (ARIC) Study.
Folsom AR; Pankow JS; Peacock JM; Bielinski SJ; Heiss G; Boerwinkle E
Diabetes Care; 2008 May; 31(5):905-9. PubMed ID: 18268068
[TBL] [Abstract] [Full Text] [Related]
20. Prevalence of common disease-associated variants in Asian Indians.
Pemberton TJ; Mehta NU; Witonsky D; Di Rienzo A; Allayee H; Conti DV; Patel PI
BMC Genet; 2008 Feb; 9():13. PubMed ID: 18248681
[TBL] [Abstract] [Full Text] [Related]
[Next]
